Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
Summary
- Eligibility
- for people ages 30 months to 17 years (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Paul Harmatz, M.D. (ucsf)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Paul Harmatz, M.D. (ucsf)
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- QED Therapeutics, Inc.
- Links
- Related Info
- ID
- NCT04035811
- Study Type
- Observational
- Participants
- Expecting 250 study participants
- Last Updated